Trial Profile
A double-blind, randomized, placebo-controlled, safety and pilot dose-response study of LL-37 in hard-to-heal venous leg ulcers
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Oct 2013
Price :
$35
*
At a glance
- Drugs Ropocamptide (Primary)
- Indications Leg ulcer
- Focus Adverse reactions
- Sponsors Lipopeptide
- 14 Oct 2013 New trial record
- 10 Oct 2013 Results published in a Pergamum media release.